In this talk, Dr Gary Kruppa presents progress in the clinical research applications of 4D-Proteomics™ since the introduction of the timsTOF Pro in 2017, in addition to recently introduced developments.
Brought to you by
Key points of Gary's discussion:
Key points of Jeffrey Spraggins's discussion:
Following our interaction with you, Bruker Daltonics and its affiliates within the Bruker group (“Bruker”) would like to be able to stay in contact with you and inform you about the latest technological achievements and upcoming events as well as the products and services offered by Bruker. If you are interested in hearing from us in the future, we will need your consent in accordance with applicable data protection laws to be allowed to engage in marketing activities using your contact information.
If you prefer not to receive promotional e-mails from Bruker in the future, you can unsubscribe at any time here.
Copyright © 2020 Bruker Scientific LLC | 40 Manning Road | Billerica, MA | 01821.
For research use only. Not for use in diagnostic procedures.